Skip to main content

Table 3 Proportion of children with worse performance on day 7 and day 28 compared to day 0, after treatment with AS7 or MAS7 for P. falciparum, and in the non febrile controls.

From: The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria

  

Day 7 - Day 0

 

Neurological Test

Component

Result compared to previous test

AS7

N = 39

MAS7

N = 39

Controls non febrile

N = 35

P*

2 × 2 a

2 × 2 b

Box

Worse

11.6 (5)

16.3 (7)

11.4 (4)

0.757

0.455

Cube

Worse

14.0 (6)

16.3 (7)

31.4 (11)

1.000

0.186

Ring

Worse

11.6 (5)

11.6 (5)

11.4 (4)

1.000

0.285

Coin

Worse

4.7 (2)

2.3 (1)

2.9 (1)

1.000

0.178

Behaviour

Worse

11.6 (5)

14.0 (6)

31.4 (11)

1.000

< 0.001

Tone

Decreased

41.9 (18)

40.5 (17)

8.8 (3)

1.000

0.026

  

Day 28 - Day 0

 

Box

Worse

5.1 (2)

7.7 (3)

9.7 (3)

1.000

0.686

Cube

Worse

15.4 (6)

20.8 (8)

16.1 (5)

0.769

1.000

Ring

Worse

5.1 (2)

7.7 (3)

25.8 (8)

1.000

0.009

Coin

Worse

5.1 (2)

5.1 (2)

9.7 (3)

1.000

0.403

Behaviour

Worse

15.4 (6)

10.3 (4)

45.2 (14)

0.737

0.001

Tone

Decreased

51.3 (20)

44.7 (17)

19.4 (6)

0.650

0.009

  1. *P value comparison of proportions a of 2 × 2 for AS7 vs MAS7, b 2 × 2 tables for malaria treatment pooled vs controls